Jason Campagna

CIK 1793338 · Chief Medical Officer · last filed 2025-02-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$474.0K

Companies

2

Total Filings

17

Lifetime Open-Market Net

-$157.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QTTB Chief Medical Officer 37,500 $12.64 $474.0K $0 2 2025-02-26
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Chief Medical Officer 20,531 $19.00 $390.1K -$157.7K 15 2021-01-26

Recent Filings · Page 2 of 2

17 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-03-17 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −69 -$5.0K EDGAR
2020-02-21 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −170 -$16.4K EDGAR
2020-01-27 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +4,200 $0 EDGAR
2020-01-08 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Sell (S) −732 -$82.7K EDGAR
2020-01-03 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −409 -$50.7K EDGAR
2019-12-20 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Sell (S) −154 -$18.4K EDGAR
2019-12-17 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Tax (F) −80 -$9.1K EDGAR
Showing 1117 of 17
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.